BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.
BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.
Recruiting · NCT07605429 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome. | Abnormalities, Multiple, Angelman syndrome, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Imprinting Disorders, central nervous system disorder, chromosomal disorder, hereditary disease, movement disorder, nervous system disorder | Recruiting | Phase 3 | 2026-09-10 | NCT07605429 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medpace, Inc. | 17 |
| OHB Pediatrics Ltd. | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rady Children's Hospital | San Diego | United States | 52 |
| Rush University | Chicago | United States | 36 |
| University of North Carolina at Chapel Hill School of Medicine | Chapel Hill | United States | 1 |